{
    "Trade/Device Name(s)": [
        "QuikResponse\u2122 One Step Midstream Early Pregnancy Test"
    ],
    "Submitter Information": "Tianjin New Bay Bioresearch Co., Ltd.",
    "510(k) Number": "k112449",
    "Predicate Device Reference 510(k) Number(s)": [
        "k030258"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "September 7, 2012",
    "Summary Letter Received Date": "September 11, 2012",
    "Submission Date": "January 11, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for QuikResponse\u2122 One Step Midstream Early Pregnancy Test for qualitative urine hCG detection",
    "Indications for Use Summary": "Over-the-counter urine test intended for qualitative detection of human Chorionic Gonadotropin (hCG) to indicate pregnancy, in some cases as early as 3 days before the expected period",
    "fda_folder": "Clinical Chemistry"
}